Richard Lake
机构: Professor University of Western Australia
每年引用次数
引用次数
引用: 12,964
H-指数: 53
I10-指数 : 108
出版物: 209
Differential induction of the NF-AT complex during restimulation and the induction of T-cell anergy
David Wotton , Julie A. Higgins , Robyn E. O'Hehir , Jonathan R. Lamb
Human Immunology 42 ( 2) 95 -102
19
1995
Antitumor efficacy of the novel chemotherapeutic agent coramsine is potentiated by cotreatment with CpG-containing oligodeoxynucleotides.
Robbert G. van der Most , Robyn Himbeck , Simon Aarons , Stephen J. Carter
Journal of Immunotherapy 29 ( 2) 134 -142
25
2006
Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors
Jonathan Chee , Mark W. Watson , Abha Chopra , Bella Nguyen
BMC Research Notes 11 ( 1) 1 -6
6
2018
Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity.
W. Joost Lesterhuis , Anthony Bosco , Michael J. Millward , Michael Small
Nature Reviews Drug Discovery 16 ( 4) 264 -272
103
2017
Loss of antigen cross-presentation after complete tumor resection is associated with the generation of protective tumor-specific CD8 + T-cell immunity
Matthew D. Brown , Robbert van der Most , Justin B. Vivian , Richard A. Lake
OncoImmunology 1 ( 7) 1084 -1094
14
2012
A T cell clone with three potential TCR α chain rearrangements expresses only one receptor combination at the cell surface
John D. Hayball , Claerwen M. Jones , Jonathan R. Lamb , Richard A. Lake
Molecular Immunology 33 ( 15) 1177 -1181
3
1996
Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations
W. Joost Lesterhuis , Catherine Rinaldi , Anya Jones , Esdy N. Rozali
Scientific Reports 5 ( 1) 12298 -12298
40
2015
A Molecular Diagnostic Test for Distinguishing Lung Adenocarcinoma from Malignant Mesothelioma Using Cells Collected from Pleural Effusions
Andrew J. Holloway , Dileepa S. Diyagama , Ken Opeskin , Jenette Creaney
Clinical Cancer Research 12 ( 17) 5129 -5135
39
2006
A better way for a cancer cell to die.
Richard A. Lake , Robbert G. van der Most
The New England Journal of Medicine 354 ( 23) 2503 -2504
52
2006
Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies.
Alistair M. Cook , Alison M. McDonnell , Richard A. Lake , Anna K. Nowak
OncoImmunology 5 ( 3)
54
2016
Combination immune checkpoint blockade as an effective therapy for mesothelioma.
Vanessa S. Fear , Caitlin Tilsed , Jonathan Chee , Catherine A. Forbes
OncoImmunology 7 ( 10)
16
2018
Dexamethasone differentially depletes tumour and peripheral blood lymphocytes and can impact the efficacy of chemotherapy/checkpoint blockade combination treatment
Wayne J. Aston , Danika E. Hope , Alistair M. Cook , Louis Boon
OncoImmunology 8 ( 11)
4
2019
Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy.
Nicola Principe , Joel Kidman , Siting Goh , Caitlin M. Tilsed
Frontiers in Immunology 11 584423 -584423
2
2020
Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy Responses
Joel Kidman , Nicola Principe , Mark Watson , Timo Lassmann
Frontiers in Immunology 11 587014 -587014
2
2020
Chemotherapy enhances cross-presentation of nuclear tumor antigens
Chidozie C. Anyaegbu , Richard A. Lake , Kathy Heel , Bruce W. Robinson
PLOS ONE 9 ( 9)
12
2014
Advances in Malignant Mesothelioma
Bruce W.S. Robinson , Richard A. Lake
The New England Journal of Medicine 353 ( 15) 1591 -1603
1,229
2005
A Novel SV40 TAg Transgenic Model of Asbestos-Induced Mesothelioma: Malignant Transformation Is Dose Dependent
Cleo Robinson , Ivonne van Bruggen , Amanda Segal , Melissa Dunham
Cancer Research 66 ( 22) 10786 -10794
71
2006
Identification of two binding sites in staphylococcal enterotoxin B that confer specificity for TCR Vβ gene products
John D. Hayball , John H. Robinson , Robyn E. O'Hehlr , Adrienne Verhoef
International Immunology 6 ( 2) 199 -211
21
1994
CD28 mRNA rapidly decays when activated T cells are functionally anergized with specific peptide.
Richard A. Lake , Robyn E. O'Hehir , Adrienne Verhoef , Jonathan R. Lamb
International Immunology 5 ( 5) 461 -466
43
1993
Transient Treg depletion enhances therapeutic anti-cancer vaccination.
Scott A. Fisher , Wayne J. Aston , Jonathan Chee , Andrea Khong
Immunity, inflammation and disease 5 ( 1) 16 -28
25
2017